Overview Fundamentals API Earnings EOD API Sample Code Pricing

Lipella Pharmaceuticals Inc. (LIPO NASDAQ) stock market data APIs

$0.4022 -0(-0%) as of July 26, 2024
Price chart is built with Anychart

Lipella Pharmaceuticals Inc., a biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. The company develops LP-10, a formulation of tacrolimus that has completed Phase 2a clinical trial for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; and LP-410, an oral liposomal formulation of tacrolimus for the treatment of oral graft-versus-host disease (GVHD). Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania.

Lipella Pharmaceuticals Inc. Financial Data Overview

0.4041
0.4022
-
0.43
0.3862
0.3611-2.71
3 147 K
7 606 K
477 K
-0.1634
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'LIPO',
Type: 'Common Stock',
Name: 'Lipella Pharmaceuticals Inc.',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG002GP9137',
ISIN: NULL,
CUSIP: NULL,
CIK: '1347242',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2022-12-19',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Lipella Pharmaceuticals Inc. Fundamental Data is available in our Financial Data APIs

  • Net Revenue 477 K
  • EBITDA -4 744 268
  • Earnings Per Share -0.74
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Lipella Pharmaceuticals Inc. Earnings via APIs

  • Latest Release 2024-05-09
  • EPS/Forecast NaN

Get Lipella Pharmaceuticals Inc. End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com